❌

Reading view

There are new articles available, click to refresh the page.

FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

Β© Ash Ponders for The New York Times

Bev Krol of Phoenix has been a participant in a trial for the drug donanemab for nearly three years. Her husband, Mark, said she began being forgetful about six years ago.

Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugs

Public employees in West Virginia who took the drugs lost weight and were healthier, and some are despondent that the state is canceling a program to help pay for them.

Β© Maddie McGarvey for The New York Times

Dr. Joanna Bailey said most of her patients in Pineville, W.Va. who need weight loss drugs don’t have insurance to cover the cost and can’t afford the sticker price.

Doctors Test the Limits of What Obesity Drugs Can Fix

β€œObesity first” doctors say they start with one medication, to treat obesity, and often find other chronic diseases, like rheumatoid arthritis, simply vanish.

Β© M. Scott Brauer for The New York Times

With Wegovy, one of the new obesity drugs, Lesa Walton not only lost more than 50 pounds; her arthritis cleared up and she no longer needed pills to lower her blood pressure, she said.
❌